(lp0
S'Regulus Therapeutics Inc.  Plunges 7.14% on March 15 Equities.com - 12 hours ago Regulus Therapeutics Inc.  had a rough trading day for Wednesday March 15 as shares tumbled 7.14%, or a loss of $-0.1 per share, to close at $1.30.Most recent Trading report: Regulus Therapeutics Inc.  - Is storiesThe Regulus Therapeutics Inc  Cut to Sell at Zacks Investment Research - Petro Global News 24'
p1
aS'RGLS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a ... PR Newswire  - Mar 13, 2017 NEW YORK, March 13, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of California on behalf of investors who purchased Regulus Therapeutics Inc.'
p2
aS'Checking in on Signals for Regulus Therapeutics Inc  Rives Journal - 16 hours ago Investors may be looking at some different technical levels in order to get a better grasp on the markets. Presently, the 14-day ADX for Regulus Therapeutics Inc  is 35.48. In general, an ADX value from 0-25 would signal an absent or weak trend.'
p3
aS'Regulus Therapeutics Inc.  Soars 8% on March 13 Equities.com - Mar 13, 2017 Regulus Therapeutics Inc.  had a good day on the market for Monday March 13 as shares jumped 8% to close at $1.35. About 1.92 million shares traded hands on 4,580 trades for the day, compared with an average daily volume of 769,199 shares out&nbsp;...'
p4
aS"Regulus Therapeutics Inc.  Soars 13.04% on March 08 Equities.com - Mar 8, 2017 Regulus Therapeutics Inc.  had a good day on the market for Wednesday March 08 as shares jumped 13.04% to close at $1.30.Rating Change on Regulus Therapeutics Inc.  - Energy IndexThe Research Analysts Offer Predictions for Regulus Therapeutics Inc's FY2017 ... - Petro Global News 24"
p5
aS"Trading Overview of Stock: Regulus Therapeutics Inc.  Is stories - 1 hour ago Regulus Therapeutics Inc.'s  witnessed a loss of -7.14% in recent trading period with closing price of $ 1.30. The company's last traded volume of 1.06 million shares as compared to it's an average volume of 0.93 million shares."
p6
aS"Regulus Reports Fourth Quarter 2016 Financial Results and Pipeline Update PR Newswire  - Mar 2, 2017 LA JOLLA, Calif., March 2, 2017 /PRNewswire/ -- Regulus Therapeutics Inc. , a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth&nbsp;...Regulus Therapeutics Inc.  Files An 8-K Results of Operations and ... - Market ExclusiveRegulus Therapeutics'  CEO Paul Grint on Q4 2016 Results - Earnings Call ... - Seeking Alpha"
p7
aS'INVESTOR NOTICE: Khang &amp; Khang LLP Announces Securities Class Action Lawsuit ... Yahoo Finance - 16 hours ago IRVINE, CA / ACCESSWIRE / March 15, 2017 / Khang &amp; Khang LLP  announces the filing of a class action lawsuit against Regulus Therapeutics Inc.  . Investors, who purchased or otherwise acquired&nbsp;...'
p8
aS'Regulus Therapeutics Inc.  Moves Lower on Volume Spike for February 17 Equities.com - Feb 17, 2017 Regulus Therapeutics Inc.  traded on unusually high volume on Feb. 17, as the stock lost 4.17% to close at $1.15. On the day, Regulus Therapeutics Inc. saw 2.02 million shares trade hands on 2,856 trades. Considering that the stock averages only ...Average Brokerage Rating Of Regulus Therapeutics Inc. , California ... - The USA CommerceRegulus Therapeutics Inc.  to Release Earnings on Monday - Chaffey Breeze'
p9
aS'IMPORTANT SHAREHOLDER ALERT: Khang &amp; Khang LLP Announces Securities Class ... Yahoo Finance - Feb 27, 2017 IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang &amp; Khang LLP  announces the filing of a class action lawsuit against Regulus Therapeutics Inc.  . Investors, who purchased or otherwise&nbsp;...IMPORTANT EQUITY NOTICE: Lundin Law PC Announces Securities Class Action ... - Baystreet.ca'
p10
a.